Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: Apparent effects of growth hormone treatment on these parameters

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 7, 2005, Pages 3978-3982

  Lanes, Roberto ^a   Soros, Arlette ^a   Flores, Karen ^a   Gunczler, Peter ^a   Carrillo, Eduardo ^a   Bandel, Jack ^a  

^a M 209 ^*

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADIPOSE TISSUE; ADOLESCENT; ARTICLE; BLOOD VESSEL FUNCTION; BODY MASS; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GROWTH HORMONE DEFICIENCY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HORMONAL THERAPY; HUMAN; HYPEREMIA; INTIMA; MALE; PRIORITY JOURNAL; RIGIDITY; VASCULAR ENDOTHELIUM; VASODILATATION;

ADIPOSE TISSUE; ADOLESCENT; BODY MASS INDEX; BRACHIAL ARTERY; CAROTID ARTERIES; ENDOTHELIUM, VASCULAR; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; MALE; MYOCARDIUM; PERICARDIUM; TUNICA MEDIA; VASODILATION; VENTRICULAR FUNCTION, LEFT;

EID: 23044513824     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0091     Document Type: Article

References (34)

1. Sacca L, Atteolini A, Fazio S 1994 Growth hormone and the heart. Endocr Rev 15:555-573
2. Lombardi G, Colao A, Marzullo P, Cuocolo A, Longobardi S, Di Somma C, Orio F, Merola B, Nicolai E, SalvatoreM1997 Is growth hormone bad for your heart: cardiovascular impact of GH deficiency and excess. J Endocrinol 155:S33-S37
3. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA 1993 Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:195-200
4. Cummings MH, Christ E, Umpleby AM 1997 Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidemia of adult growth hormone deficiency. J Clin Endocrinol Metab 82:2010-2013
5. Abdu TAM, Neary R, Elhaad TA, Akber M, Clayton RN 2001 Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clin Endocrinol (Oxf) 55:209-216
6. Kissebah AH, Krakower GR 1994 Regional adiposity and morbidity. Physiol Rev 74:761-811
7. Johannsson G, Albertsson-Wikland K 1999 Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. J Clin Endocrinol Metab 84:4516-4524
8. Merola B, Cittadini A, Colao A, Longobardi S, Fazio S, Sabatini D, Sacco L, Lmbardi G 1993 Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency, J Clin Endocrinol Metab 77:1658-1661
9. Longobardi S, Cuocolo A, Merola B, Di Rella D, Colao A, Nicolai E, Cardei S, Salvatore M, Lombardi G 1998 Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol (Oxf) 48:137-143
10. Johansson JO, Landin K, Tengborn L, Rosen T, Bengsson BA 1999 High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults. Arteroscler Thromb 76:422-428
11. Al-Shoumer KAS, Cox KH, Hughes CL, Richmond, Johnston DG 1997 Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. J Clin Endocrinol Metab 82:2653-2659
12. Hoffman AR, Kuntze JE, Baptista J, Baum HBA, Baumann GP, Biller BM, Clark RV, Cook D, Inzucchi SE, Kleinberg D, Klibanski A, Phillips LS, Ridgway EC, Robbins RJ, Schechte J, Sharma M, Thorner MO, Vance ML 2004 Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89:2048-2056
13. Colao A, Di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G 2001 Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab 86:1874-1881
14. Valcalvi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I 1995 Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 86:659-666
15. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Sacca L, Bellastella A 1993 Body composition, bone metabolism and heart structure and function in growth hormone (GH) deficient adults before and afterGHreplacement therapy at low doses. J Clin Endocrinol Metab 77:1671-1676
16. Shulman DI, Root AW, Diamond FB, Bercu BB, Martinez R, Boucek RJ 2003 Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency. J Clin Endocrinol Metab 88:4095-4099
17. Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, Tanturri L, Lombardi G, Colao A 2004 Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy. Clin Endocrinol (Oxf) 60:630-636
18. Capaldo B, Patti L, Oliviero U, Longobardi S, Pardo F, Vitale F, Fazio S, Di Rella F, Biondi B, Lombardi G, Sacca L 1997 Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 82:1378-1381
19. Elhadd TA, Abdu TA, Oxtoby J, Kennedy G, McLaren M, Neary R, Belch JJF, Clayton RN 2001 Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. J Clin Endocrinol Metab 86:4223-4232
20. Twickler TB, Dallinga-Thie GM, Visseren FLJ, De Vries WR, Erkelens DW, Kopperschaar HPF 2003 Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle-cholesterol concentration. J Clin Endocrinol Metab 88:1228-1233
21. Leonsson M, Hulthe J, Johannsson G, Wiklund O, Wikstrandt J, Bengtsson BA, Oscarsson J 2003 Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness. Clin Endocrinol (Oxf) 59:242-250
22. Lanes R, Paoli M, Carrillo E, Villaroel O, Palacios A 2004 Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency. Relation to postprandial dyslipidemia. J Pediatr 145:657-661
23. Pfeifer MM, Verhovec R, Zizek B 1999 Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 84:453-457
24. Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF, Davies JS 2002 Effects of GH replacement on endothelial function and large artery stiffness in GH-deficient adults: a randomized, double-blind, placebocontrolled study. Clin Endocrinol (Oxf) 56:493-501
25. Abdu TAM, Elhadd TA, Buch H, Barton D, Neary R, Clayton RN 2004 Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated and relative coronary risk. Clin Endocrinol (Oxf) 61:387-393
26. Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R 2001 Cardiac mass and function, carotid artery intima-media thickness and lipoprotein levels in growth hormone deficient adolescents. J Clin Endocrinol Metab 86:1061-1065
27. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F 2003 Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88:5163-5168
28. Lanes R, Recker B, Fort P, Lifshitz F 1985 Low dose oral clonidine: a simple and reliable growth hormone screening test for children. Am J Dis Child 139:87-89
29. Donnadieu M, Evain-Brion D, Tonon MCl, Vaudry H, Job JC 1985 Variations of plasma growth hormone (GH)-releasing factor levels duringGHstimulation tests in children. J Clin Endocrinol Metab 60:1132-1134
30. Sahn DJ, DeMaria A, KIsslo J, Weyman A 1978 Recommendations regarding quantification in M-mode echocardiography; results of a survey of echocardiographic measurements. Circulation 58:1072-1083
31. Schiller NB, Shaah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al 1989 Recommendations for quantification of the LV by 2 dimensional echocardiography. J Am Soc Echocardiogr 2:358-367
32. Tsukahara RH, Gordienko DV, Tonshoff B, Gelato MC, GoligorskyMS1994 Direct demonstration of insulin-like growth factor-induced nitric oxide production by endothelial cells. Kidney Int 45:598-604
33. Caidahl K, Eden S, Bengtsson BA 1994 Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf) 41:615-620
34. Lanes R, Paoli M, Carrillo E, Villaroel O, Palacios A 2003 The cardiovascular risk of growth hormone deficient adolescents: differences in growth hormone treated and untreated subjects. Horm Res 60:291-295